Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,751.05",
    "chg": 7.9,
    "chgp": "0.12%",
    "dir": 1,
    "prev_price": "6,743.15",
    "mcapval": "179,455.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "23:55 PM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "2.56 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4068328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_mojoScore_4068328.png",
        "date": "2026-06-23 08:17:20",
        "description": "Divis Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting a marked improvement in its technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 22 June 2026, is underpinned by robust quarterly results, bullish technical signals, and sustained long-term outperformance relative to benchmarks, signalling renewed investor confidence in the pharmaceutical giant."
      },
      {
        "title": "Divis Laboratories Gains 1.63%: Mixed Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-163-mixed-signals-shape-weekly-momentum-4065754",
        "imagepath": "",
        "date": "2026-06-20 17:04:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Stock opens at Rs.6,608.15 amid Hold rating downgrade</p>\n                    <p><strong>16 Jun:</strong> Downgrade to Hold announced, mixed valuation and technical signals</p>\n                    <p><strong>17 Jun:</strong> Technical momentum shifts to bullish, stock rises 1.59%</p>\n                    <p><strong>19 Jun:</strong> Week closes at Rs.6,741.15, up 1.63% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,633.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-4058096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_technicaldot_4058096.png",
        "date": "2026-06-17 08:02:39",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in technical momentum, transitioning from a mildly bullish stance to a more assertive bullish trend. This change is underscored by a confluence of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling renewed investor confidence despite recent market headwinds."
      },
      {
        "title": "Divis Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4055333",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_mojoScore_4055333.png",
        "date": "2026-06-16 08:18:21",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong fundamentals and robust quarterly performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm."
      },
      {
        "title": "Divis Laboratories Gains 0.14%: 7 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-014-7-key-factors-driving-the-weeks-mixed-momentum-4051467",
        "imagepath": "",
        "date": "2026-06-13 13:08:56",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Sharp open interest surge amid price decline (Rs.6,516.35, -1.62%)</p>\n                    <p><strong>9 Jun:</strong> Intraday high of Rs.6,787.95 with 3.4% surge and heavy call/put option activity</p>\n                    <p><strong>10 Jun:</strong> Upgrade to Buy rating on strong technical and financial performance (Close Rs.6,756.40, +3.68%)</p>\n                    <p><strong>11 Jun:</strong> Technical momentum shifts amid mixed indicator signals (Close Rs.6,638.90, -1.74%)</p>\n                    <p><strong>12 Jun:</strong> Week closes at Rs.6,633.05 (-0.27%) with Sensex gaining 2.20%</p>\n                </div>\n\n                <div class=\"stats-row\">\n          ..."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4045830",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_technicaldot_4045830.png",
        "date": "2026-06-11 08:02:16",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a modest day decline of 1.74%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key indicator readings, and the implications for investors navigating the evolving market landscape."
      },
      {
        "title": "Divis Laboratories Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-upgraded-to-buy-on-strong-technical-and-financial-performance-4043460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_mojoScore_4043460.png",
        "date": "2026-06-10 08:07:14",
        "description": "Divis Laboratories Ltd has been upgraded from Hold to Buy following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects improved technical momentum, robust quarterly financials, and sustained long-term outperformance against benchmarks, signalling renewed investor confidence in this large-cap pharmaceutical player."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4043260",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_technicaldot_4043260.png",
        "date": "2026-06-10 08:02:52",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in technical momentum, with key indicators signalling a bullish trend. The stock’s recent price action, combined with improved technical parameters such as MACD, moving averages, and Bollinger Bands, suggests growing investor confidence amid a strong sectoral backdrop."
      },
      {
        "title": "Divis Laboratories Ltd Rallies 3.4% and Approaches 52-Week High Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-high-with-34-surge-on-9-june-2026-4040942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DivisLaboratori_priceRelatedfactors_4040942.png",
        "date": "2026-06-09 10:01:05",
        "description": "The Sensex edged up 0.27% on 09 Jun 2026, but Divis Laboratories Ltd surged 3.4%, outpacing its Pharmaceuticals &amp; Biotechnology sector by over 3 percentage points. This sharp single-session gain rewrites the short-term narrative for the stock, which now stands just 4.77% shy of its 52-week high."
      }
    ],
    "total": 654,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2025-26",
      "datetime": "11-Jun-2026",
      "details": "As per enclosed letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Jun-2026",
      "details": "Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "29-May-2026",
      "details": "Submission of transcript of Earnings Conference Call held on May 23 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-06-23 08:17:20

Divis Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting a marked improvement in its technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 22 June 2026, is underpinned by robust quarterly results, bullish technical signals, and sustained long-term outperformance relative to benchmarks, signalling renewed investor confidence in the pharmaceutical giant.

Read full news article

Divis Laboratories Gains 1.63%: Mixed Signals Shape Weekly Momentum

2026-06-20 17:04:22

Key Events This Week

15 Jun: Stock opens at Rs.6,608.15 amid Hold rating downgrade

16 Jun: Downgrade to Hold announced, mixed valuation and technical signals

17 Jun: Technical momentum shifts to bullish, stock rises 1.59%

19 Jun: Week closes at Rs.6,741.15, up 1.63% for the week

Week Open

Rs.6,633.05

Week Close

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators

2026-06-17 08:02:39

Divis Laboratories Ltd has exhibited a notable shift in technical momentum, transitioning from a mildly bullish stance to a more assertive bullish trend. This change is underscored by a confluence of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling renewed investor confidence despite recent market headwinds.

Read full news article

Divis Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-06-16 08:18:21

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 15 June 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong fundamentals and robust quarterly performance, evolving market dynamics and valuation concerns have tempered investor enthusiasm.

Read full news article

Divis Laboratories Gains 0.14%: 7 Key Factors Driving the Week’s Mixed Momentum

2026-06-13 13:08:56

Key Events This Week

8 Jun: Sharp open interest surge amid price decline (Rs.6,516.35, -1.62%)

9 Jun: Intraday high of Rs.6,787.95 with 3.4% surge and heavy call/put option activity

10 Jun: Upgrade to Buy rating on strong technical and financial performance (Close Rs.6,756.40, +3.68%)

11 Jun: Technical momentum shifts amid mixed indicator signals (Close Rs.6,638.90, -1.74%)

12 Jun: Week closes at Rs.6,633.05 (-0.27%) with Sensex gaining 2.20%

...

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-11 08:02:16

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a modest day decline of 1.74%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical parameter changes, key indicator readings, and the implications for investors navigating the evolving market landscape.

Read full news article

Divis Laboratories Upgraded to Buy on Strong Technical and Financial Performance

2026-06-10 08:07:14

Divis Laboratories Ltd has been upgraded from Hold to Buy following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects improved technical momentum, robust quarterly financials, and sustained long-term outperformance against benchmarks, signalling renewed investor confidence in this large-cap pharmaceutical player.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-10 08:02:52

Divis Laboratories Ltd has exhibited a notable shift in technical momentum, with key indicators signalling a bullish trend. The stock’s recent price action, combined with improved technical parameters such as MACD, moving averages, and Bollinger Bands, suggests growing investor confidence amid a strong sectoral backdrop.

Read full news article

Divis Laboratories Ltd Rallies 3.4% and Approaches 52-Week High Amid Sector Outperformance

2026-06-09 10:01:05

The Sensex edged up 0.27% on 09 Jun 2026, but Divis Laboratories Ltd surged 3.4%, outpacing its Pharmaceuticals & Biotechnology sector by over 3 percentage points. This sharp single-session gain rewrites the short-term narrative for the stock, which now stands just 4.77% shy of its 52-week high.

Read full news article

View All News